This study evaluates the use of Rhodiola rosea in the attention of adults with Attention Deficit/Hyperactivity Disorder (ADHD). Half of participants will receive Rhodiola rosea 800mg, while the other half will receive 800mg of placebo.
The evaluation of new therapies in adults with Attention Deficit/Hyperactivity Disorder (ADHD) may be clinically useful. Rhodiola rosea is an herbal medicine used for centuries in various medical conditions. Many randomized controlled trials have evaluated its usefulness in stress and fatigue. There were benefits in attention in some of these studies. Mild side effects and beneficial antioxidant properties make reasonable an assessment of its potential benefits in adults with ADHD. To our knowledge, Rhodiola rosea has never been studied in adults with ADHD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
60
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
RECRUITINGChange in Stop Signal Task
Change from baseline attention 4 hours after a single dose of Rhodiola 800mg or placebo
Time frame: Baseline and 4 hours
Change in Wechsler Adult Intelligence Scale (WAIS) - Digit Span subtest
Change from baseline attention 4 hours after a single dose of Rhodiola 800mg or placebo
Time frame: Baseline and 4 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.